Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovaBay Pharmaceuticals

0.6100
-0.0200-3.17%
Volume:13.42K
Turnover:8.35K
Market Cap:2.98M
PE:-0.05
High:0.6699
Open:0.6051
Low:0.6051
Close:0.6300
Loading ...

NovaBay accepts revised transaction proposal from PRN

TIPRANKS
·
07 Nov 2024

NovaBay Pharmaceuticals: Accepts Revised Offer From Nutriceuticals, Enters Into Amendment to Asset Purchase Agreement to Increase Purchase Price

THOMSON REUTERS
·
07 Nov 2024

BRIEF-NovaBay Pharmaceuticals Board Determines Unsolicited Offer Is Superior To Asset Purchase Agreement With PRN Physician Recommended Nutriceuticals, LLC

Reuters
·
29 Oct 2024

NovaBay Pharmaceuticals: Refresh's Offer Also Includes Refresh Providing a Secured Term Loan to Co in Principal Amount of $2.0 Mln

THOMSON REUTERS
·
29 Oct 2024

NovaBay Pharmaceuticals Board Determines Unsolicited Offer Is Superior to Asset Purchase Agreement With Prn Physician Recommended Nutriceuticals, Llc

THOMSON REUTERS
·
29 Oct 2024

NovaBay Pharmaceuticals: Under Refresh's Offer Co Would Receive a Purchase Price of up to $11.5 Mln

THOMSON REUTERS
·
29 Oct 2024

NovaBay Pharmaceuticals Shares up 55% at 77 Cents After Co Signs Deal to Sell Assets of Eye Care Brand Avenova

THOMSON REUTERS
·
20 Sep 2024

NovaBay Pharma Signs Deal to Sell Avenova Assets to Acumen Health Unit for $9.5 Million; Shares Soar

MT Newswires Live
·
20 Sep 2024

Acumen Health Holdings ("Acumen") to Acquire the Avenova Brand From NovaBay Pharmaceuticals

THOMSON REUTERS
·
20 Sep 2024

Press Release: Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals

Dow Jones
·
20 Sep 2024

Morning Brew: Microsoft Boosts Dividends, FedEx Slumps on Guidance, and Nvidia Partners for Climate

GuruFocus
·
20 Sep 2024

Novabay Pharmaceuticals Signs Definitive Agreement To Sell Its Avenova Assets

T-Reuters
·
20 Sep 2024

NovaBay Pharmaceuticals Signs Definitive Agreement to Sell Its Avenova Assets

THOMSON REUTERS
·
20 Sep 2024